Kennedy CDC Vaccine Panel Changes
- has appointed eight members to the Centers for Disease Control and prevention's (CDC) Advisory Committee for Immunization Practices (ACIP), a key panel that advises the agency on vaccine...
- The ACIP provides recommendations on who should receive vaccines after they gain approval from the U.S.
- Of the eight appointees—the minimum number required by the ACIP charter—four have prior experience on committees associated with the CDC, the FDA, or both, shaping the future of...
U.S. Health Secretary Robert Kennedy Jr. shakes up the centers for Disease Control and Prevention’s (CDC) Advisory Committee for Immunization Practices (ACIP) by appointing eight new members to the vaccine advisory panel. These individuals will now advise on vaccine recommendations, a change that follows the dismissal of all 17 members of the self-reliant expert committee. The new appointees include those wiht documented histories of anti-vaccine advocacy and prior experience on committees associated with the CDC and FDA, stirring debate about the future of vaccine policy.News Directory 3 brings you this breaking update and will continue reporting on the implications of these appointments on public health decisions across the United States. Discover what’s next as the panel convenes.
Robert Kennedy Jr. Appoints Vaccine advisers to CDC Panel
Updated June 12, 2025
U.S. health Secretary Robert Kennedy Jr. has appointed eight members to the Centers for Disease Control and prevention’s (CDC) Advisory Committee for Immunization Practices (ACIP), a key panel that advises the agency on vaccine use. The move follows the dismissal of all 17 members of the independant expert committee.
The ACIP provides recommendations on who should receive vaccines after they gain approval from the U.S. Food and Drug Administration (FDA). The newly appointed group includes individuals who have previously voiced opposition to vaccines.
Of the eight appointees—the minimum number required by the ACIP charter—four have prior experience on committees associated with the CDC, the FDA, or both, shaping the future of vaccine policy and recommendations.
What’s next
The new panel is expected to convene to discuss and formulate recommendations regarding vaccine schedules and policies,influencing public health decisions related to immunization programs across the United States.